FDA label
What is Sprycel used for?
Sprycel contains dasatinib. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “SPRYCEL (dasatinib) is indicated for the treatment of adult patients with”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Sprycel?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Sprycel, tablet
Indications and Usage, quoted from the label by E.R. Squibb & Sons, L.L.C. (NDA021986). Cross-references to other label sections are left out.
SPRYCEL (dasatinib) is indicated for the treatment of adult patients with
- newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
- chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.
- Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
SPRYCEL (dasatinib) is indicated for the treatment of pediatric patients 1 year of age and older with
- Ph+ CML in chronic phase.
- newly diagnosed Ph+ ALL in combination with chemotherapy.
Source: DailyMed label, set id 4764f37b-c9e6-4ede-bcc2-8a03b7c521df, version 49, effective September 15, 2026. NDC 0003-0524, one of 6 listings for this product.
Questions
What is Sprycel used for?
The FDA label says: “SPRYCEL (dasatinib) is indicated for the treatment of adult patients with”
What drug class is Sprycel?
FDA lists dasatinib in the Kinase Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.